Ensysce Biosciences, Inc. (ENSC) NASDAQ
0.29
-0.0283(-8.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.29
-0.0283(-8.94%)
Currency In USD
| Market Cap | 2.35M |
| Enterprise Value | -4T |
| P/E Ratio | -0.07 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.53 |
| Price/Book Ratio | 0.23 |
| Enterprise/Revenue | -790,195.36 |
| Enterprise/EBITDA | 854,338.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -2.01 |
| Operating Margin | -2.02 |
| Return On Assets | -1.37 |
| Return On Equity | -3.75 |
| Revenue | 5.07M |
| Revenue/Share | 1.98 |
| Gross Profit | 0 |
| EBITDA | -10.15M |
| Net Income | -10.18M |
| Diluted EPS | -3.98 |
| Total Cash | 4.31T |
| Total Cash/Share | 1.69M |
| Total Debt | 306.71B |
| Total Debt/Equity | 95,437.06 |
| Current Ratio | 1.59 |
| Book Value Per Share | 1.13 |
| 52-Week Change | -86.08 |
| 52-Week High | 2.75 |
| 52-Week Low | 0.28 |
| Moving Average 50 Days | 0.48 |
| Moving Average 200 Days | 1.34 |
| Average Volume | 7.63M |
| Shares Outstanding | 9.28M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | December 06, 2024 |